Skip to main content
Yolanda Tseng, MD, Radiation Oncology, Seattle, WA, Fred Hutchinson Cancer Center

YolandaTsengMD

Radiation Oncology Seattle, WA

Clinical Fellow in Radiation Oncology, Brigham and Women's Hospital

Dr. Tseng is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Tseng's full profile

Already have an account?

Education & Training

  • Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical School
    Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Radiation Oncology, 2010 - 2014
  • Brigham and Women's Hospital
    Brigham and Women's HospitalResidency, Internal Medicine, 2009 - 2010
  • Harvard Medical School
    Harvard Medical SchoolClass of 2009

Certifications & Licensure

  • WA State Medical License
    WA State Medical License 2014 - 2025
  • MA State Medical License
    MA State Medical License 2011 - 2016
  • American Board of Radiology Radiation Oncology

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • Low Achievement of End of Life Quality Measures in Large B-Cell Lymphoma Patients Who Progressed after CD19-Specific CAR-T Cell Therapy
    Yolanda D. Tseng, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • High Rate of Exclusion of HIV Infected Patients from Modern Lymphoma Studies: An Analysis of Current United States Therapeutic Trials
    Yolanda D. Tseng, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Impact of Lab Abnormalities at the Time of Progression in Patients Receiving CD19-Specific CAR T-Cell Therapy for Relapsed/Refractory Large B-Cell Lymphomas
    Yolanda D. Tseng, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Lectures

  • Outcomes of Patients with Large B-Cell Lymphomas and Progressive Disease Following CD19-Specific CAR T-Cell TherapyClinically Relevant Abstract 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

  • Society for Palliative Radiation Oncology: Report from the Fifth Annual Meeting (2018)
    Society for Palliative Radiation Oncology: Report from the Fifth Annual Meeting (2018)February 1st, 2019

Hospital Affiliations